Lipolytic substance injections to reduce localized fat have been extensively used because it is a low-invasive method. This review aimed to evaluate the efficacy and safety of deoxycholic acid in submental fat reduction compared to a placebo and investigate the potential industry sponsorship bias in the results of randomized clinical trials on this topic. Ten electronic databases were extensively searched for randomized clinical trials without restriction on language and year of publication. Two reviewers extracted the data and assessed the individual risk of bias in the studies with the RoB 2.0 tool. The industry sponsorship bias was evaluated according to citations in the articles regarding industry funding/sponsorship throughout the texts. Fixed and random effects meta-analyses were performed, and the results were reported in Risk Ratio (RR) at a 95% Confidence Interval (95% CI). The initial search provided 5756 results, of which only five were included. Only two studies had a low risk of bias. All studies showed a potential industry bias. The meta-analysis showed that patients treated with deoxycholic acid had significant positive results for all efficacy outcomes and a higher risk of fibrosis, pain, erythema, numbness, swelling, edema, pruritus, nodules, headache, and paresthesia. The low to moderate certainty of evidence found allows concluding that deoxycholic acid is effective in submental fat reduction, causing well-tolerated adverse effects. However, all eligible studies showed a potential industry bias.
7 August 2020 in Research, Society and Development
Introduction: Bruxism is defined as a parafunctional chewing activity characterized by the clenching and / or grinding of teeth that occurs both during sleep and during the surveillance period. Methods: Thirty female patients between 18 and 40 years old who had bruxism and orofacial pain were selected and randomized into two groups: control group (n = 15), where individuals received 0.05 ml of sterile saline solution that was applied to the bundle anterior temporal muscles and 0.2 ml for each masseter muscle, and an experimental group (n = 15), individuals received 20 units of A-botulinum toxin (Botox®) applied to each masseter muscle and 5 units of A-botulinum toxin applied to the anterior bundle of each temporal muscle. Patients were called back for reevaluation every thirty days. At these moments, they underwent an evaluation of the load force and electromyography. Results: At 30, 60, 90 and 120 days, a decrease in electromyographic activity was observed in the A-botulinum toxin group (p
28 February 2021 in Brazilian Journal of Health Review
“Kissing Molars” (KMs) é um tipo incomum de impacção dentária, definido como molares inclusos com íntimo contato das superfícies oclusais em um único espaço folicular e raízes apontando em direções opostas. Este estudo teve como objetivo investigar e descrever, por meio de uma revisão narrativa da literatura, evidências sobre KMs, agrupando informações de etiologia, classificação, prevalência, diagnóstico, tratamento e complicações desta rara impacção. Para isso, realizou-se uma pesquisa por publicações em 7 bases de dados eletrônicas, utilizando as palavras chaves: "kissing molars" OR "kissing molar" OR "kiss of molars" OR "kissing teeth" OR "rosetting of molars" OR "rosetting of molar". Além disso, foi efetuada busca manual por citações nas publicações inicialmente selecionadas. Estudos com pelo menos um caso clínico de KMs que descrevessem características clínicas, diagnósticas e/ou terapêuticas foram incluídos. Foram encontrados 179 artigos segundo os critérios pré-estabelecidos para coleta de dados, e apenas 37 foram incluídos nesta revisão. Os resultados mostraram que um total de 64 casos de KMs são descritos na literatura, mas há poucas informações disponíveis sobre prevalência, o fator etiológico permanece desconhecido e não há diretrizes definidas para tratamento.
Purpose: To summarize the available evidence and answer the following question: What is the current knowledge on the performance of blood concentrates in handling sequelae after lower third molar extractions with the evidence available in systematic reviews?